Search Results
Results found for "Johnson & Johnson"
Posts (7)
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Elizabeth Johnstone were awarded one of the 2022 Diabetes Research Grants at the World Diabetes Day Breakfast "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of
Other Pages (2)
- Celtarys Research | Dr. GPCR Ecosystem
over 20 years of experience in the medtech and diagnostics industries, having held senior roles at Johnson & Johnson and Danaher across the EMEA region in sales, marketing, and general management.
- Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires | Dr. GPCR Ecosystem
Johnson explains why the circuit matters more than the receptor. << Back to podcast list Strategic Partner (s) Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires The brain circuits governing ABOUT THE GUEST Kari Johnson is an assistant professor of neuropharmacology at the Uniformed Services The gap is consequential, and Johnson named it directly. Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.
